Jonathan Schoenfeld Answers: Which Patients Benefit Most from Immunotherapy and Radiation
Jonathan Schoenfeld discusses the patient profile that would benefit best from a combination of radiation and immunotherapy.
Jonathan Schoenfeld, MD, MPhil, MPH, of Dana-Farber Cancer Institute, discusses which patients would benefit most from a combination of immunotherapy and radiation treatment.
Right now, patients with local or locally-advanced disease, or with suppressed immune systems are not thought to be the best candidates for immunotherapy. However, Schoenfeld believes that will change with the advances being made.